Enliven Therapeutics Inc (NASDAQ: ELVN) started the day on Thursday, with a price decrease of -3.38% at $25.17, before settling in for the price of $26.05 at the close. Taking a more long-term approach, ELVN posted a 52-week range of $13.30-$29.98.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 19.02%. Meanwhile, its Annual Earning per share during the time was 19.02%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.68%. This publicly-traded company’s shares outstanding now amounts to $59.26 million, simultaneously with a float of $43.26 million. The organization now has a market capitalization sitting at $1.49 billion.
Enliven Therapeutics Inc (ELVN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Enliven Therapeutics Inc’s current insider ownership accounts for 27.10%, in contrast to 78.42% institutional ownership. According to the most recent insider trade that took place on Jan 09 ’26, this organization’s CHIEF OPERATING OFFICER sold 48,300 shares at the rate of 27.99, making the entire transaction reach 1,351,762 in total value, affecting insider ownership by 215,011. Preceding that transaction, on Jan 09 ’26, Company’s CHIEF SCIENTIFIC OFFICER sold 91,198 for 27.22, making the whole transaction’s value amount to 2,482,578. This particular insider is now the holder of 765,188 in total.
Enliven Therapeutics Inc (ELVN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
Enliven Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 8.68% and is forecasted to reach -2.02 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -15.94% through the next 5 years, which can be compared against the 19.02% growth it accomplished over the previous five years trading on the market.
Enliven Therapeutics Inc (NASDAQ: ELVN) Trading Performance Indicators
Let’s observe the current performance indicators for Enliven Therapeutics Inc (ELVN). It’s Quick Ratio in the last reported quarter now stands at 32.95.
In the same vein, ELVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.85, a figure that is expected to reach -0.38 in the next quarter, and analysts are predicting that it will be -2.02 at the market close of one year from today.
